• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO 2.25/15; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO 2.25/15; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 364481
Device Problem Failure to Deflate (4060)
Patient Problem Myocardial Infarction (1969)
Event Date 10/31/2023
Event Type  Injury  
Manufacturer Narrative
Combination product: yes.
 
Event Description
The orsiro drug-eluting stent system was chosen for treatment of mildly calcified lesion (80 percent stenosis degree) in the mildly tortuous mid om1.After pre-dilatation the stent was delivered smoothly.During inflation the balloon was expanding very slowly and no air was identifiable.After deflation the balloon remained fully expanded.No flushing, inflator change, multiple attempts of negative pressure application resolved the issue.Finally, a 50 ccm syringe was attached and a constant negative pressure was applied with simultaneous manual traction.The balloon was slowly evacuated.It revealed fully inflated.Due to the prolonged vessel occlusion the signs and symptoms of stemi developed.The patient was managed medically without any further consequences.
 
Manufacturer Narrative
Combination product: yes.Neither the affected product nor the angiographic material was returned.Therefore, no technical investigation on the subject could be performed.The production documentation was reviewed to establish whether a deviation from the manufacturing process could be the cause for the reported event.Review of the production documentation verified that the device was manufactured according to specifications and fulfilled all the requirements of in-process and final inspection.Based on the conducted investigations, no material or manufacturing related root cause could be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO 2.25/15
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
Manufacturer Contact
6024 jean road
lake oswego, OR 97035
8772459800
MDR Report Key18243199
MDR Text Key329427709
Report Number1028232-2023-06064
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier07640130411463
UDI-Public(01)07640130411463(17)2405
Combination Product (y/n)Y
Reporter Country CodeCH
PMA/PMN Number
P170030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/25/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/30/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number364481
Device Catalogue NumberSEE MODEL NO.
Device Lot Number05220096
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/25/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/16/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-